Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,920 signal articles · 44 in last 24h · 135,691 total before filter · latest 43m ago
44last 24h
1096last 7d
179● bullish (7d)
141● bearish (7d)
209publishers
AllMacro301Earnings359M&A77Regulatory25Product11Analyst14
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Q2 Earnings Season Standout Performers: PLTR, MSFT
Zacks18d agoneutral
Q2 Earnings Season Standout Performers: PLTR, MSFT

The Q2 earnings season continues to wind down, which has overall shown immense strength with outsized growth. There have been several standout releases during the Q2 earnings cycle, including those from Palantir (PLTR) and Microsoft (MSFT).

Fabrinet Q4 Earnings Call Highlights
MarketBeat18d agoneutral
Fabrinet Q4 Earnings Call Highlights

Fabrinet (NYSE:FN) reported record fourth-quarter results for fiscal 2026, with revenue rising 45% year over year to $1.316 billion and non-GAAP earnings per share reaching $4.10, above the company’s guidance range. The fiscal fourth quarter ended June 26, 2026. For the full fiscal year, revenue in

XP Inc.A (XP) Tops Q2 Earnings Estimates
Zacks18d agobullish
XP Inc.A (XP) Tops Q2 Earnings Estimates

XP Inc.A (XP) delivered earnings and revenue surprises of +3.92% and -1.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

HIVE Digital Technologies Q1 Earnings Call Highlights
MarketBeat19d agoneutral
HIVE Digital Technologies Q1 Earnings Call Highlights

HIVE Digital Technologies (NASDAQ:HIVE) reported fiscal first-quarter 2027 revenue of $79.1 million, up 73% from $45.6 million a year earlier and 10% sequentially, as the company expanded its Bitcoin mining operations and continued building its high-performance computing, or HPC, and artificial inte

ICU Medical (ICUI): Buy, Sell, or Hold Post Q2 Earnings?
StockStory19d agoneutral
ICU Medical (ICUI): Buy, Sell, or Hold Post Q2 Earnings?

ICU Medical has had an impressive run over the past six months as its shares have beaten the S&P 500 by 9.3%. The stock now trades at $182.79, marking a 23.3% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Syntec Optics Q2 Earnings Call Highlights
MarketBeat19d agoneutral
Syntec Optics Q2 Earnings Call Highlights

Syntec Optics (NASDAQ:OPTX) reported record second-quarter revenue for 2026, returning to operating and net profitability as sales increased across its medical, defense, consumer and communications markets. Revenue for the quarter totaled approximately $8.3 million, up 26% from approximately $6.6 m